Dr. Charles Knox Everett, MD

Dr. Everett practices at Mid Peninsula Endoscopy Center in Burlingame, California.

Dr. Everett's NPI, 1316147382, was assigned on July 18, 2007. Dr. Everett graduated from Vagelos College of Physicians and Surgeons in 2005. Dr. Everett holds California license A98566.

Dr. Everett's primary practice is Mid Peninsula Endoscopy Center, at 1720 El Camino Real, Suite 100, Burlingame, CA 94010. The practice phone is (650) 373-1970.

Dr. Everett's primary practice is Mid Peninsula Endoscopy Center in Burlingame, California. Dr. Everett is also affiliated with Mills-Peninsula Medical Center. The medical group on file is Pulmonary Associates. Dmand AI also links Dr. Everett to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Everett practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Everett's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Everett is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Everett is licensed in California.

Dmand AI lists asthma, bronchitis, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pleural effusion, pneumonia, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Everett treats.

CMS data shows 1,030 Medicare services from Dr. Everett across 15 procedure codes in 2024, for 421 Medicare patients. Medicare paid $118,411 for them.

CMS counts 421 Medicare patients who saw Dr. Everett in 2024. The largest group is 75 to 84, with 187 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Everett's median patient age at 75, with 51% women.

In 2024, Dr. Everett wrote 2,197 Medicare Part D claims for 297 patients. CMS names the drug for 2,031 of them, across 41 drugs with 11 or more claims each, at $1,864,086 in total drug cost. In 2023, CMS named 1,986 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Everett for performance year 2024, reported individually. Dr. Everett accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Everett as offering telehealth.

Dmand AI links 8 papers to Dr. Everett, published from 2011 to 2018. The most frequent topics are CD4 Lymphocyte Count, HIV Infections and Mycobacterium tuberculosis. Dr. Everett's most frequent co-authors are Laurence Huang, MD, Adithya Cattamanchi, MD and Nicholas Walter, MD.

CMS Open Payments shows 485 general payments to Dr. Everett from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $2,184.

Dr. Everett graduated from Vagelos College of Physicians and Surgeons in 2005.

Dr. Everett is in network with 13 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.